Goleta-based Community West Bancshares reports loss
Goleta-based Community West Bancshares, parent company of Community West Bank, reported a loss of $2.3 million in the second quarter of 2015 following a $7.2 million loan settlement. The company recorded a profit of $1.7 million in the same period last year. “Community West’s second quarter results included solid loan and deposit growth and strong Read More →
Camarillo-based Interlink Electronics reports increased revenues
Camarillo-based Interlink Electronics, a tech company that focuses on manufacturing sensors that are used in portable electronic devices, saw revenues increase by 6 percent from $2.7 million during the second quarter last year to $2.8 million this year. Interlink posted earnings of 8 cents per share, an improvement of 1 cent from the same quarter Read More →
Revenues down but Thousand Oaks-based Teledyne beats estimates
Thousand Oaks-based Teledyne Technologies beat analyst estimates when it reported second-quarter earnings on July 30 but the company still saw a sharp decline in net income. Teledyne posted earnings of $1.34 per share, barely beating analyst estimates of $1.33 per share. Second-quarter revenues were down by 3.2 percent from the second-quarter of 2014, from $597.1 Read More →
Camarillo-based Salem Media Group beats expectations
Camarillo-based Salem Media Group beat analyst expectations when it reported second-quarter earnings of 14 cents per share on Aug. 5. Analysts predicted Salem Media Group would earn just 4 cents per share. Salem’s revenues declined by 2 percent from $68.6 million during the second quarter of last year to $67.3 million. This still beat analyst Read More →
Westlake Village-based Kythera Biopharmaceuticals reports second quarter loss
Westlake Village-based Kythera Biopharmaceuticals missed analyst estimates when it released second quarter earnings on Aug. 6. Kythera lost $1.44 per share, missing analyst estimates of a loss of $1.10 per share. For the quarter, Kythera lost $37.2 million, compared to $19.5 million during the second quarter of 2014. On June 17, Allergan announced that it Read More →